{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:45:29Z","timestamp":1793411129401,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/dad.0000000000000348","type":"journal-article","created":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T15:32:19Z","timestamp":1448119939000},"page":"924-928","source":"Crossref","is-referenced-by-count":22,"title":["Blastic Plasmacytoid Dendritic Cell Neoplasm in the Pediatric Population"],"prefix":"10.1097","volume":"37","author":[{"given":"Catherine M.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Skupsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arline","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Cassarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210202","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","article-title":". Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.","volume":"95","author":"Jegalian","year":"2010","journal-title":"Haematologica"},{"key":"R2-10-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaad.2009.08.044","article-title":". Cutaneous CD4 CD56 hematologic malignancies.","volume":"63","author":"Magro","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R3-10-20210202","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajh.2830470406","article-title":". High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.","volume":"47","author":"Adachi","year":"1994","journal-title":"Am J Hematol"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/FY6PK436NBK0RYD4","article-title":"The features of an evolving entity and its relationship to dendritic cells.","volume":"127","author":"Herling","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R5-10-20210202","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000172194.32918.5c","article-title":". CD4() CD56() lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.","volume":"29","author":"Reichard","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.humpath.2005.07.002","article-title":". CD4 CD56 hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.","volume":"36","author":"Urosevic","year":"2005","journal-title":"Hum Pathol"},{"key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/gcc.22119","article-title":". CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm.","volume":"53","author":"Tokuda","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1525-1470.2005.22104.x","article-title":". Cutaneous tumors as the initial presentation of non-T, non-B, nonmyeloid CD4 CD56 hematolymphoid malignancy in an adolescent boy.","volume":"22","author":"Fass","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"R11-10-20210202","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bjd.12412","article-title":". Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.","volume":"169","author":"Julia","year":"2013","journal-title":"Br J Dermatol"},{"key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","article-title":". Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasmmorphologic and phenotypic variability in a series of 33 patients.","volume":"34","author":"Cota","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R13-10-20210202","first-page":"1","article-title":". Blastic plasmacytoid dendritic cell neoplasm.","volume":"3","author":"Facchetti","year":"2009","journal-title":"Hematol Meeting Rep"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/cyto.a.22072","article-title":". Intracytoplasmic detection of TCL1but not ILT7by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis.","volume":"81A","author":"Angelot-Delettre","year":"2012","journal-title":"Cytometry A"},{"key":"R15-10-20210202","first-page":"74","article-title":"Bagot M, et al..","volume":"162","author":"Dalle","year":"2010","journal-title":"Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice Br J Dermatol"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","article-title":". Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation.","volume":"121","author":"Roos-Weil","year":"2013","journal-title":"Blood"},{"key":"R17-10-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/pbc.20034","article-title":". Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.","volume":"42","author":"Hyakuna","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R18-10-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","article-title":". Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.","volume":"124","author":"Frankel","year":"2014","journal-title":"Blood"},{"key":"R19-10-20210202","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":". Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.","volume":"145","author":"Garnache-Ottou","year":"2009","journal-title":"Br J Haematol"},{"key":"R20-10-20210202","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":". The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"key":"R21-10-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1525-1470.2011.01586.x","article-title":"Childhood blastic plasmacytoid dendritic cell neoplasm treated with allogenic stem cell transplantation.","volume":"30","author":"Gambichler","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R22-10-20210202","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00431-013-2248-4","article-title":". Diffuse lung metastases in a child with blastic plasmacytoid dendritic cell neoplasm and review.","volume":"173","author":"Zhong","year":"2014","journal-title":"Eur J Pediatr"},{"key":"R23-10-20210202","first-page":"ECR48","article-title":". Childhood CD4CD56 hematodermic neoplasm: case report and review of the literature.","volume":"91","author":"Ruggiero","year":"2006","journal-title":"Haematologica"},{"key":"R24-10-20210202","doi-asserted-by":"crossref","first-page":"E140","DOI":"10.1002\/pbc.24622","article-title":". Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.","volume":"60","author":"Sakashita","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R25-10-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.bmt.1703597","article-title":". Successful treatment of relapsed blastic natural killer cell lymphoma with unrelated cord blood transplantation.","volume":"30","author":"Yoshimasu","year":"2002","journal-title":"Bone Marrow Transplant"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000000348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:01:27Z","timestamp":1620950487000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201512000-00010"}},"subtitle":["A Case Series and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000348","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}